NCT05399420 (ADNIRA) is a clinical trial of Blood sampling in Kidney Failure, Acute, sponsored by CGenetix.

Who is sponsoring NCT05399420?

NCT05399420 is sponsored by CGenetix.

What drugs are being tested in NCT05399420?

Interventions in NCT05399420: Blood sampling.

What condition does NCT05399420 study?

NCT05399420 studies Kidney Failure, Acute.

Is NCT05399420 still recruiting?

NCT05399420 is currently status unknown. Last updated 1 June 2022.

Last reviewed 2022-06-01 · How we verify

NCT05399420: ADNIRA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study of Kidney Circulating Cell-free DNA in Patients With Acute Kidney Failure

Status unknown Last updated 1 June 2022

What this trial tests

trial testing Blood sampling in Kidney Failure, Acute in 90 participants. Status unknown.

Timeline

10 September 2022

Primary endpoint
20 December 2022

10 January 2023

Quick facts

Lead sponsor	CGenetix
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	90
Start date	10 September 2022
Primary completion	20 December 2022
Estimated completion	10 January 2023

Drugs / interventions tested

Blood sampling — full drug profile →

Conditions studied

Kidney Failure, Acute — all drugs for Kidney Failure, Acute →

Sponsor

CGenetix

Who can join

Adults 18 to 99, any sex, with Kidney Failure, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The amount of total circulating DNA has been shown to increase in patients with acute renal failure. Nevertheless, it is currently not currently possible to prove the renal origin of this circulating DNA. Recently, in healthy subjects, teams have shown that it is possible to identify its tissue origin of circulating DNA. CGenetix is a MedTech company which develops on an identical principle an in vitro diagnostic test capable of identifying and quantifying renal degradation during an acute trauma. The objective of this study is to evaluate the sensitivity of the proposed technology to detect circulating DNA of renal origin released into the general circulation in patients with acute organic and functional renal failure. Patients with functional or organic kidney deficiency will be included and the kidney biomarkers develop by CGenetix will be compared between these 2 groups of patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Blood sampling

Trials testing the same drug.

NCT07372859 — Women's Heart: Impact of Ultra-endurance and Hormonal Profile on Cardiac and Systemic Inflammatory Parameters in Female · NA · not yet recruiting
NCT07237984 — Colorectal Omics and ofCS Proteoglycans (COCO) in Screening and a Diagnostic Pathway · not yet recruiting
NCT06544018 — Circadian Rhythm Deregulation in Patients With CAPS · NA · recruiting
NCT07245550 — Thyroid and Adrenal Disorders in ICU · not yet recruiting
NCT07033091 — Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening · NA · recruiting

Other recruiting trials for Kidney Failure, Acute

Currently open trials in the same condition.

NCT06781294 — SIRAKI 02 Posthoc Analysis. · NA · active not recruiting
NCT06707532 — The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA) · NA · recruiting
NCT06129617 — Intermittent ADVOS vs. Hemodialysis in Non-intensive Care Patients With Liver Dysfunction · NA · recruiting
NCT04446858 — Non-invasive Evaluation of the Predictive Value of CEUS and SWE in ACLF, Renal Failure and Hepatorenal Syndrome · recruiting
NCT04334707 — Kidney Precision Medicine Project · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05399420 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by CGenetix
Last refreshed: 1 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05399420.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing